印度禁止90种未经批准的组合药物, 包括常用药品. India bans 90 unapproved combo drugs, including common meds, over safety and legality concerns.

印度药品总监已对90种未经批准的固定剂量组合药物进行全国范围内的打击, 包括常见的类型如甲酸盐和多维生素等. 在2025年SUGAM实验室测试发现这些药物是根据印度法律不被批准的"新药". The Drug Controller General of India has launched a nationwide crackdown on 90 unapproved fixed-dose combination drugs, including common medications like Paracetamol and multivitamins, after SUGAM lab tests in 2025 found them to be unapproved "new drugs" under Indian law. 美国药品监督管理局 (DCGI) 命令各州和联邦区的药物管制机构调查制造商和分销商,停止生产和销售,并提交紧急行动报告. The DCGI ordered state and union territory drug controllers to investigate manufacturers and distributors, halt production and sales, and submit urgent action reports, stressing that these drugs violate the Drugs and Cosmetics Act, 1940, and the New Drugs and Clinical Trial Rules, 2019. 这一举动是确保药物安全和监管合规的首要公共卫生任务. The move is a top public health priority to ensure drug safety and regulatory compliance.